Infectious Disease News Current Issue

The following articles appeared in the print edition of Infectious Disease News.

Table of Contents

• Measles resurgence in US compounded by nonmedical vaccine exemptions
• 2-drug HIV regimen maintains virologic suppression at 148 weeks
• Achaogen, maker of newly approved Zemdri, files for bankruptcy
• Artesunate becomes first-line treatment for severe malaria in US
• NIAID awards $22 million to develop therapies for lethal viruses
• Recipients of HCV-positive hearts and lungs successfully treated with DAAs
• Q&A: The evolution of CAUTI and need for better metrics
• Should pediatric patients be able to make their own decisions on vaccination?
• Monkeypox, a close relative of smallpox, is still with us Donald Kaye, MD, MACP; Thomas M Yuill, PhD
• Recommended treatment options scarce for pregnant women with HIV
• WHO says Ebola outbreak still not an international health emergency
• Hooked on ID with Cassandra Calabrese, DO Cassandra Calabrese, DO
• Beta-lactam test-dose procedures safe in patients with reported allergy
• Diagnostic algorithm simplifies surveillance of deep SSIs
• Glecaprevir/pibrentasvir safe, effective in cirrhotic patients with HCV
• IV fosfomycin effective in treating complicated UTIs
• Kids are prescribed more antibiotics with telemedicine
• Live-camel handlers at higher risk for MERS-CoV infection
• Model identifies primate species most likely to spread Zika in the Americas
• Monoclonal antibody demonstrates ‘unprecedented’ virologic suppression in HIV study
• Newly admitted patients’ hands commonly contaminated with MDROs, including MRSA
• PrEP associated with increase in STIs among gay, bisexual men
• Short-course therapy similarly effective to prolonged therapy for P. aeruginosa
• Survival times improved in favipiravir-treated Ebola patients
• Swift response kept humans safe during ‘massive’ anthrax outbreak in wildlife
• Waiting to vaccinate older adults may reduce flu cases, deaths
• Cost-benefit analysis shows MenB vaccination ‘clear choice’ over treatment
• DIAMOND study: 48-week results show long-term efficacy of Symtuza
• HCWs can be convinced to get flu vaccine without making it mandatory
• Jet injector effective and efficient for delivering flu vaccine
• Redfield: CDC priorities include opioid epidemic, ending HIV
• Petting zoos harbor potentially dangerous MDR bacteria
• Zerbaxa noninferior to meropenem for treating nosocomial pneumonia
• Mechanisms of carbapenem resistance: CP or not CP? Is that the question? Leah Molloy, PharmD